FBTCX Mutual Fund

FBTCX Mutual Fund (Fidelity Advisor Biotechnology Fund Class C) is managed by Fidelity Investments (US) with $66.7M in net assets. FBTCX expense ratio is 1.69%, holding 131 positions across sectors including Health Care, Financials, Industrials. Inception date: 2000-12-27.

FBTCX performance shows a YTD return of 28.53%. The 1-year return is 34.37% and the 5-year return is 12.15%. FBTCX dividend yield stands at 1.05%, paid annually.

FBTCX top holdings include Abbvie Inc. (13.8%), Gilead Sciences Inc (6.0%), Alnylam Pharmaceuticals Inc. (3.8%), Insmed Inc (3.4%), Amylyx Pharmaceuticals Inc (3.4%). Go to all FBTCX holdings, FBTCX sectors, or FBTCX dividends.

FBTCX can be compared against other funds. Use FBTCX overlap to find shared positions, or FBTCX vs another fund for a side-by-side view. FBTCX alternatives are available via the screener, along with tax-loss harvesting opportunities.